Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma
Related Experiment Video
Updated: Oct 9, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
1Division of Haematology, Department of Medicine, Karolinska Hospital and Karolinska Institutet, Stockholm, Sweden. Chengyun.Zheng@cmm.ki.se
Abstract:
Multiple myeloma (MM) is a B-lineage malignancy with unknown aetiology. It has been considered that predisposing genetic factors might be implicated in the disease. In this study, the microsatellite polymorphism in the exon 3 of the cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene was analysed in patients with MM and monoclonal gammopathy of undetermined significance (MGUS), together with ethnically matched healthy controls. The results showed that frequencies of the genotype 86/86 and of the allele 86 were significantly decreased in MM and MGUS compared with matched healthy controls, indicating that the CTLA-4 microsatellite polymorphism might represent a susceptibility locus for MM and MGUS.
